Mink Therapeutics Inc
NASDAQ:INKT
Income Statement
Earnings Waterfall
Mink Therapeutics Inc
Income Statement
Mink Therapeutics Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(19)
|
(22)
|
(25)
|
(29)
|
(31)
|
(29)
|
(28)
|
(25)
|
(23)
|
(21)
|
(18)
|
(14)
|
(11)
|
(10)
|
(11)
|
(12)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(7)
|
(8)
|
(8)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(4)
|
(4)
|
(5)
|
(6)
|
|
| Research & Development |
(14)
|
(16)
|
(18)
|
(21)
|
(23)
|
(22)
|
(21)
|
(18)
|
(15)
|
(14)
|
(11)
|
(10)
|
(8)
|
(7)
|
(7)
|
(6)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
1
|
1
|
1
|
(1)
|
|
| Operating Income |
(19)
N/A
|
(22)
-18%
|
(25)
-15%
|
(29)
-17%
|
(31)
-5%
|
(29)
+5%
|
(28)
+5%
|
(25)
+10%
|
(23)
+9%
|
(21)
+9%
|
(18)
+16%
|
(14)
+19%
|
(11)
+22%
|
(10)
+10%
|
(11)
-12%
|
(12)
-12%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(13)
|
(12)
|
(10)
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
1
|
(0)
|
1
|
3
|
3
|
3
|
2
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(30)
N/A
|
(34)
-13%
|
(34)
+1%
|
(26)
+23%
|
(28)
-8%
|
(26)
+7%
|
(26)
0%
|
(25)
+5%
|
(22)
+9%
|
(21)
+8%
|
(17)
+17%
|
(14)
+19%
|
(11)
+22%
|
(10)
+10%
|
(11)
-16%
|
(12)
-10%
|
|
| Net Income | |||||||||||||||||
| Income from Continuing Operations |
(30)
|
(34)
|
(34)
|
(26)
|
(28)
|
(26)
|
(26)
|
(25)
|
(22)
|
(21)
|
(17)
|
(14)
|
(11)
|
(10)
|
(11)
|
(12)
|
|
| Net Income (Common) |
(30)
N/A
|
(34)
-13%
|
(34)
+1%
|
(26)
+23%
|
(28)
-8%
|
(26)
+7%
|
(26)
0%
|
(25)
+5%
|
(22)
+9%
|
(21)
+8%
|
(17)
+17%
|
(14)
+19%
|
(11)
+22%
|
(10)
+10%
|
(11)
-16%
|
(12)
-10%
|
|
| EPS (Diluted) |
-11.6
N/A
|
-10.19
+12%
|
-10.08
+1%
|
-7.69
+24%
|
-8.31
-8%
|
-7.62
+8%
|
-7.55
+1%
|
-7.18
+5%
|
-6.53
+9%
|
-5.94
+9%
|
-4.6
+23%
|
-3.48
+24%
|
-2.72
+22%
|
-2.45
+10%
|
-2.84
-16%
|
-2.78
+2%
|
|